TrialFind
Saved trials
Back to results
Completed
Phase 2
Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease
NCT05423522
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
CHU de Lille
Lille, France
+7 additional locations
View on ClinicalTrials.gov
Official details
Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease — TrialFind